subject: The reluctance to invest in 'pure' R&D is understandable. "D [print this page] The reluctance to invest in 'pure' R&D is understandable. "Developing a new molecule is highly risky as it needs both time and money. Chances of failure are high and sometimes an investment of Rs 1,000 Gibson Les Paul Custom crore is needed to develop a single molecule," says Satish Kantheti, joint managing director,
